InVivo Therapeutics Corpの時価総額
InVivo Therapeutics Corpの時価総額は何ですか。
InVivo Therapeutics Holdings Corpの時価総額は3.51M$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
NASDAQのセクタHealth Careにおける時価総額の企業と比べるInVivo Therapeutics Corp
InVivo Therapeutics Corpは何をしますか。
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
InVivo Therapeutics Corpと類似の時価総額
- Raptisの時価総額は3.50M$です。
- Stakeholder Goldの時価総額は3.50M$です。
- Alcoの時価総額は3.50M$です。
- Dillistone Plcの時価総額は3.50M$です。
- Appreciated Mediaの時価総額は3.50M$です。
- Candela Invest SAの時価総額は3.51M$です。
- InVivo Therapeutics Corpの時価総額は3.51M$です。
- Southern Hemisphere Miningの時価総額は3.51M$です。
- Pinedaleの時価総額は3.51M$です。
- Steed Oriental ()の時価総額は3.51M$です。
- OCL Iron and Steelの時価総額は3.51M$です。
- Radient Technologiesの時価総額は3.51M$です。
- Zenith Healthcareの時価総額は3.51M$です。